Total Funding
6
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 6 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Neuronix’s mission is to turn Dementia a Manageable Chronic Disease, by introducing new methods for modifying the course of treatment for
- Eyal Baror: CEO
About the Company
Neuronix’s mission is to turn Dementia a Manageable Chronic Disease, by introducing new methods for modifying the course of treatment for Neuro-degenerative Diseases and in particular Alzheimer Disease (AD). Thus, offering hope and long-term improvement in the quality of life of patients. Led by a highly motivated management team and supported by
an Advisory Board made up of key opinion leaders in the field, Neuronix’s neuroAD technology is currently undergoing advanced clinical trials in major medical centers across the globe.
